76 related articles for article (PubMed ID: 9618412)
1. Activation of human liver 3alpha-hydroxysteroid dehydrogenase by clofibrate derivatives.
Matsuura K; Hara A; Kato M; Deyashiki Y; Miyabe Y; Ishikura S; Sugiyama T; Katagiri Y
J Pharmacol Exp Ther; 1998 Jun; 285(3):1096-103. PubMed ID: 9618412
[TBL] [Abstract][Full Text] [Related]
2. Dual effects of anti-inflammatory 2-arylpropionic acid derivatives on a major isoform of human liver 3alpha-hydroxysteroid dehydrogenase.
Yamamoto T; Matsuura K; Shintani S; Hara A; Miyabe Y; Sugiyama T; Katagiri Y
Biol Pharm Bull; 1998 Nov; 21(11):1148-53. PubMed ID: 9853403
[TBL] [Abstract][Full Text] [Related]
3. Activation of human liver 3 alpha-hydroxysteroid dehydrogenase by sulphobromophthalein.
Matsuura K; Tamada Y; Deyashiki Y; Miyabe Y; Nakanishi M; Ohya I; Hara A
Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):179-84. PubMed ID: 8546681
[TBL] [Abstract][Full Text] [Related]
4. Effects of clofibric acid and bezafibrate administration on activities of alkaline phosphatase and other enzymes in livers of rats.
Walli AK; Seidel D
Res Exp Med (Berl); 1981; 179(2):153-61. PubMed ID: 7280363
[TBL] [Abstract][Full Text] [Related]
5. Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: heterogeneity monooxygenase responses.
Facino RM; Carini M
Pharmacol Res Commun; 1981 Oct; 13(9):861-71. PubMed ID: 7335763
[No Abstract] [Full Text] [Related]
6. Retention of NADPH-linked quinone reductase activity in an aldo-keto reductase following mutation of the catalytic tyrosine.
Schlegel BP; Ratnam K; Penning TM
Biochemistry; 1998 Aug; 37(31):11003-11. PubMed ID: 9692994
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of liver glutathione S-transferase activity in rats by hypolipidemic drugs related or unrelated to clofibrate.
Foliot A; Touchard D; Mallet L
Biochem Pharmacol; 1986 May; 35(10):1685-90. PubMed ID: 3707598
[TBL] [Abstract][Full Text] [Related]
8. Mutagenesis of 3 alpha-hydroxysteroid dehydrogenase reveals a "push-pull" mechanism for proton transfer in aldo-keto reductases.
Schlegel BP; Jez JM; Penning TM
Biochemistry; 1998 Mar; 37(10):3538-48. PubMed ID: 9521675
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of highly water-soluble fibrate derivatives via BGLation.
Nemoto H; Kamiya M; Nakamoto A; Matsushita T; Matsumura K; Hattori H; Kawamura T; Taoka C; Abe S; Ishizawa K; Miyamoto L; Tsuchiya K
Bioorg Med Chem Lett; 2012 Oct; 22(20):6425-8. PubMed ID: 22975299
[TBL] [Abstract][Full Text] [Related]
10. Involvement of two basic residues (Lys-270 and Arg-276) of human liver 3 alpha-hydroxysteroid dehydrogenase in NADP(H) binding and activation by sulphobromophthalein: site-directed mutagenesis and kinetic analysis.
Matsuura K; Tamada Y; Sato K; Iwasa H; Miwa G; Deyashiki Y; Hara A
Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):89-93. PubMed ID: 9078247
[TBL] [Abstract][Full Text] [Related]
11. Urinary glucuronide excretion of fenofibric and clofibric acid glucuronides in man. Is it polymorphic?
Liu HF; Vincent-Viry M; Galteau MM; Guéguen R; Magdalou J; Nicolas A; Leroy P; Siest G
Eur J Clin Pharmacol; 1991; 41(2):153-9. PubMed ID: 1743248
[TBL] [Abstract][Full Text] [Related]
12. Engineering steroid 5 beta-reductase activity into rat liver 3 alpha-hydroxysteroid dehydrogenase.
Jez JM; Penning TM
Biochemistry; 1998 Jul; 37(27):9695-703. PubMed ID: 9657682
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
Weithmann KU; Granzer E
Artery; 1980; 8(5):475-81. PubMed ID: 7011266
[TBL] [Abstract][Full Text] [Related]
14. [Experimental research on the action of a derivative from a p-chloropenoxyisobutyric acid series on lipid parameters].
Filip M; Hriscu A; Păduraru I; Rusu M
Rev Med Chir Soc Med Nat Iasi; 1986; 90(1):156-60. PubMed ID: 3764166
[No Abstract] [Full Text] [Related]
15. Branched chain amino acid oxidation in cultured rat skeletal muscle cells. Selective inhibition by clofibric acid.
Pardridge WM; Casanello-Ertl D; Duducgian-Vartavarian L
J Clin Invest; 1980 Jul; 66(1):88-93. PubMed ID: 7400311
[TBL] [Abstract][Full Text] [Related]
16. Human liver class I alcohol dehydrogenase gammagamma isozyme: the sole cytosolic 3beta-hydroxysteroid dehydrogenase of iso bile acids.
Marschall HU; Oppermann UC; Svensson S; Nordling E; Persson B; Höög JO; Jörnvall H
Hepatology; 2000 Apr; 31(4):990-6. PubMed ID: 10733557
[TBL] [Abstract][Full Text] [Related]
17. Fibrates reduce triacylglycerol content by upregulating adipose triglyceride lipase in the liver of rats.
Karahashi M; Hoshina M; Yamazaki T; Sakamoto T; Mitsumoto A; Kawashima Y; Kudo N
J Pharmacol Sci; 2013; 123(4):356-70. PubMed ID: 24292381
[TBL] [Abstract][Full Text] [Related]
18. Structure-specific effects of thyroxine analogs on human liver 3 alpha-hydroxysteroid dehydrogenase.
Yamamoto T; Nozaki A; Shintani S; Ishikura S; Katagiri Y; Hara A
J Biochem; 2000 Jul; 128(1):121-8. PubMed ID: 10876166
[TBL] [Abstract][Full Text] [Related]
19. Effects of fibric acid derivatives on biliary lipid composition.
Palmer RH
Am J Med; 1987 Nov; 83(5B):37-43. PubMed ID: 3318452
[TBL] [Abstract][Full Text] [Related]
20. Kinetic alteration of a human dihydrodiol/3alpha-hydroxysteroid dehydrogenase isoenzyme, AKR1C4, by replacement of histidine-216 with tyrosine or phenylalanine.
Ohta T; Ishikura S; Shintani S; Usami N; Hara A
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):685-91. PubMed ID: 11104674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
